DDIs in HIV Webinar: Real Cases, Expert Insights
Explore our DDI in HIV webinars
Explore our webinar series on drug–drug interactions (DDIs) in HIV treatment, featuring expert insights and real-life clinical cases. Revisit the key takeaways from the 2025 and 2026 editions and discover practical insights into managing drug interactions in clinical practice.
2025 Webinar | Drug–Drug Interactions in HIV
Explore real-world evidence and clinical considerations on drug–drug interactions, including the performance of unboosted integrase inhibitors, the impact of enzyme inducers on treatment outcomes, and the often-overlooked role of over-the-counter medications and alternative therapies.
2026 Webinar | DDIs Between Antiretrovirals and Oncology Medications
Discover three clinical cases exploring drug–drug interactions between antiretroviral and other medications, with a focus on oncology treatments. The webinar examines interactions between dolutegravir and paclitaxel, bictegravir and rifabutin, and doravirine and ursodeoxycholic acid.
